September 15, 2016 8:00 am
The history of science shows that irreproducibility is not a product of our times. Some 350 years ago, the chemist Robert Boyle penned essays on “the unsuccessfulness of experiments”. He warned readers to be sceptical of reported work. “You will meet with several Observations and Experiments, which … may upon further tryal disappoint your expectation.” He attributed the problem to a ‘lack of skill in the scientist and the lack of purity of the ingredients’, and what would today be referred to as inadequate statistical power.
September 9, 2016 8:00 am
The scandal surrounding Paolo Macchiarini, the former star surgeon who became famous for his pioneering trachea transplants, has prompted yet another round of resignations and firings at the highest levels of Swedish higher education. On Monday evening, Swedish Minister for Higher Education and Research Helene Hellmark Knutsson said she had dismissed the country’s chancellor in charge of all public universities, Harriet Wallberg-Henriksson, following the release of a sharply critical report by an independent commission that examined the Karolinska Institute’s (KI’s) hiring and management of Macchiarini. Wallberg-Henriksson was vice-chancellor of KI in Stockholm, a position comparable to that of a university president, when Macchiarini was hired, and played a key role in his recruitment.
June 30, 2014 6:15 pm
Facebook is unapologetic about the “emotional contagion” experiment it was conducting on customers.
April 23, 2014 1:40 pm
The settlement ends a case brought by the ex-head of UCLA’s orthopedic surgery department, who says the medical school allowed doctors to take industry payments that may have compromised patient care.
April 17, 2014 5:37 pm
Free samples of prescription drugs may seem like a great deal for patients. But even when doctors think they’re doing patients a favor by handing out the freebies, the real beneficiaries are the drug manufacturers, according to new research in the journal JAMA Dermatology.
December 17, 2013 6:00 pm
GlaxoSmithKline will stop paying doctors for promoting its drugs and scrap prescription targets for its marketing staff – a first for an industry battling scandals over its sales practices, and a challenge for its peers to follow suit.
November 8, 2013 1:41 pm
Regulatory policy should be based on rules that are clear, with a process that is transparent, and on decisions that are accountable and reviewable, and that are congruent with other public policy imperatives.
October 15, 2013 2:35 pm
Even though medical students and trainees were interacting with industry less than before, roughly half of all medical students and residents had received some kind of gift from industry.
September 23, 2013 3:51 pm
Seventeen of 18 scientists who wrote a controversial editorial critical of the European Commission’s plan to regulate endocrine-disrupting chemicals have past or current ties to industries.
August 19, 2013 2:13 pm
An unprecedented Oregon Department of Justice investigation has stepped into an ethical minefield with national implications: When should patients know about a doctor’s payments from companies whose products they use, and whose responsibility is it to tell them?